GCTK: GlucoTrack Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for GCTK
Across the 6 sessions after earlier GCTK headlines, the stock closed higher 1 times and lower 5 times, with a median move of 9.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GCTK | SPY |
|---|---|---|---|
| Jan 29, 2026 | Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | -33.4% | -0.2% |
| Dec 30, 2025 | Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor | -10.9% | -0.1% |
| Nov 14, 2025 | Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights | -8.6% | -0.0% |
| Nov 4, 2025 | Glucotrack, Inc. Encourages Shareholders to Vote | -5.9% | -1.2% |
| Oct 30, 2025 | Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team | -0.3% | -1.1% |
| Oct 28, 2025 | Glucotrack, Inc. Reminds Shareholders to Vote | +9.9% | +0.3% |
Quantisnow market dataNASDAQ
GCTK
GlucoTrack Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for GCTK
Full GCTK profile on Quantisnow Follow GCTK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time